Clinical Trials Archives - Mesothelioma Hub

The International Mesothelioma Program is a center for mesothelioma at the Brigham and Women’s Hospital in Boston, Massachusetts.

International Symposium on Malignant Mesothelioma, hosted by the Mesothelioma Applied Research Foundation, will be held July 22-23 of 2022.

A non-invasive treatment that combines chemotherapy with electrical currents to shrink mesothelioma tumors appear to be working for patients.

The phase II OT-101 clinical trial will study a promising treatment option for patients with pleural mesothelioma.

Mesothelioma clinical trials work to advance treatment for patients. Learn more about 5 current mesothelioma clinical trials.

Researchers have developed targeted treatment with heat-activated gold spheres (nanotubes) to help with killing mesothelioma tumors.

An anticipated new mesothelioma clinical trial involving a novel drug, RSO-021, will take place at the University of Vermont Cancer Center.

A new cancer treatment (known as monoclonal antibodies) is helping COVID-19 patients with underlying conditions avoid hospitalization.

A promising new artificial intelligence (AI) tool could streamline the process of identifying mesothelioma tumors in patients.

Scientists and researchers are testing new CAR-T cell treatment methods in clinical trials. Learn the timeline and what to expect.

Mesothelioma Hub is dedicated to helping you find information, support, and advice. Reach out any time!

Treatment and Research at the International Mesothelioma Program